Suppr超能文献

在无已知恶性肿瘤的患者中检测到的持续性肺部亚实性结节的体积和质量倍增时间。

Volume and mass doubling times of persistent pulmonary subsolid nodules detected in patients without known malignancy.

机构信息

From the Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine, Seoul National University Medical Research Center, 101 Daehangno, Jongno-gu, Seoul 110-744, Korea (Y.S.S., C.M.P., S.J.P., S.M.L., J.M.G.); Cancer Research Institute, Seoul National University, Seoul, Korea (C.M.P., S.J.P., J.M.G.); and Department of Pathology, Seoul National University College of Medicine, Seoul, Korea (Y.K.J.).

出版信息

Radiology. 2014 Oct;273(1):276-84. doi: 10.1148/radiol.14132324. Epub 2014 Jun 14.

Abstract

PURPOSE

To evaluate volume doubling time (VDT) and mass doubling time (MDT) of persistent pulmonary subsolid nodules (SSNs) followed-up with low-dose (LD) computed tomography (CT) in patients without a history of malignancy.

MATERIALS AND METHODS

This retrospective institutional review board-approved study, with waiver of patient informed consent, included 97 SSNs in 97 patients (45 men, 52 women; median age, 58 years; range, 37-87 years) in whom at least two LD CT scans were obtained, with 3-month or longer follow-up interval and median follow-up of 633 days. SSNs were categorized into pure ground-glass nodules (GGNs) (group A), part-solid GGNs with solid components of 5 mm or smaller (group B), and part-solid GGNs with solid components larger than 5 mm (group C). Three-dimensional manual segmentation for all SSNs was performed on initial and latest follow-up LD CT scans; subsequently, VDTs and MDTs were calculated and were compared among groups by using Kruskal-Wallis test, followed by the Dunn procedure with Bonferroni correction for volume-growing SSNs and mass-growing SSNs.

RESULTS

Volume growth was thus: 12 of 63 SSNs (19%), group A; nine of 23 SSNs (39%), group B; and eight of 11 SSNs (73%), group C. Median VDT was thus: 1832.3 days (range, 1230.7-4537.3 days), group A; 1228.5 days (range, 934.7-4617.7 days), group B; and 759.0 days (range, 376.4-941.5 days), group C. Mass growth was thus: 17 of 63 SSNs (27%), group A; 11 of 23 SSNs (48%), group B; and nine of 11 SSNs (82%), group C. Median MDT was 1556.1 days (range, 642.5-3564.5 days) for group A, 1199.9 days (range, 838.6-2578.7 days) for group B, and 627.7 days (range, 340.0-921.2 days) for group C. Median VDTs and MDTs of groups A and B were significantly longer than those of group C (P < .01).

CONCLUSION

Pure GGNs and part-solid GGNs with solid components of 5 mm or smaller show significantly longer VDTs and MDTs than do part-solid GGNs with solid components larger than 5 mm. Online supplemental material is available for this article.

摘要

目的

评估无恶性肿瘤病史患者行低剂量 CT 随访的持续性肺部亚实性结节(SSN)的体积倍增时间(VDT)和质量倍增时间(MDT)。

材料与方法

本回顾性研究经机构审查委员会批准,患者无需知情同意,并豁免该程序。共纳入 97 例患者的 97 个 SSN(45 名男性,52 名女性;中位年龄为 58 岁;范围:37-87 岁),这些患者至少进行了两次 LD CT 扫描,随访时间间隔至少为 3 个月,中位随访时间为 633 天。SSNs 分为纯磨玻璃结节(GGN)(A 组)、部分实性 GGN 且实性成分≤5mm(B 组)和部分实性 GGN 且实性成分>5mm(C 组)。在初始和最新的 LD CT 扫描上对所有 SSNs 进行三维手动分割;随后,计算 VDT 和 MDT,并使用 Kruskal-Wallis 检验比较各组间的 VDT 和 MDT,体积增长的 SSNs 和质量增长的 SSNs 采用 Dunn 程序,Bonferroni 校正。

结果

体积生长情况为:63 个 SSN 中有 12 个(19%),A 组;23 个 SSN 中有 9 个(39%),B 组;11 个 SSN 中有 8 个(73%),C 组。VDT 中位数分别为:A 组为 1832.3 天(范围:1230.7-4537.3 天);B 组为 1228.5 天(范围:934.7-4617.7 天);C 组为 759.0 天(范围:376.4-941.5 天)。质量生长情况为:63 个 SSN 中有 17 个(27%),A 组;23 个 SSN 中有 11 个(48%),B 组;11 个 SSN 中有 9 个(82%),C 组。A 组 MDT 中位数为 1556.1 天(范围:642.5-3564.5 天),B 组为 1199.9 天(范围:838.6-2578.7 天),C 组为 627.7 天(范围:340.0-921.2 天)。A 组和 B 组的 VDT 和 MDT 中位数明显长于 C 组(P<.01)。

结论

纯 GGN 和部分实性 GGN 且实性成分≤5mm 的 VDT 和 MDT 明显长于部分实性 GGN 且实性成分>5mm。本文提供了在线补充材料。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验